LBA8 Nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722

Tony Mok, K. Nakagawa, K. Park, Y. Ohe, N. Girard, H.R. Kim, Yi‐Long Wu, J. Gainor, SH Lee, C-H. Chiu, K. Sang-We, Y. Cheng-Ta, W. Liang, Lin Wu, Lin Mc, J. Samol, X. Zhang, J. Sylvester, S. Li, J.C-H. Yang